Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01719822

Enrollment

155

Registered

2012-11-01

Start date

2012-07-31

Completion date

2015-02-28

Last updated

2015-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchitis, Chronic, Lung Diseases, Obstructive, Pulmonary Disease, Chronic Obstructive

Keywords

Treatment Outcome [E01.789.800], Rehabilitation [N02.421.784], Physical Fitness [I03.621], Lung Diseases, Obstructive [C08.381.495], Pulmonary Disease, Chronic Obstructive [C08.381.495.389], Bronchitis, Chronic [C08.381.495.389.500]

Brief summary

Patients with chronic lung diseases such as Chronic Obstructive Pulmonary Disease (COPD), who perform regular physical activity, have improved health and wellbeing compared with those who do little exercise. The purpose of the study is to evaluate whether the use of a simple pedometer (step counter) to set targets for daily physical activity can encourage COPD patients referred for an 8-week pulmonary exercise based programme (PR) to be more active. The investigators also want to know whether the use of pedometers during PR can improve adherence, self-management and outcome in COPD.

Interventions

DEVICEYamax Digi-Walker CW-700

A pedometer with a daily step count target set by a physiotherapist.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* All patients with COPD

Exclusion criteria

* Any patient in whom mobility and lower limb function have been significantly affected by a neuromuscular disease, severe peripheral vascular disease or amputation * Any patient whom the chief investigator feels it is unsafe to exercise (eg. unstable cardiac disease)

Design outcomes

Primary

Measure	Time frame
Change from baseline of time spent in at least moderate physical activity (3>METS equivalent)	8 weeks

Secondary

Measure	Time frame
Change from baseline of Incremental Shuttle Walk	8 weeks
Change from baseline of Chronic Respiratory Disease Questionaire (CRDQ)	8 weeks
Change from baseline of Medical Outcomes Survey Short Form 36 item questionaire SF-36	8 weeks

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026